List of Tables
Table 1. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Asset purchase
Table 3. Key Players of Assignment
Table 4. Key Players of Co-development
Table 5. Key Players of Co-market
Table 6. Key Players of Co-promotion
Table 7. Key Players of Collaborative R&D
Table 8. Key Players of Contract service
Table 9. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2020-2025)
Table 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2026-2031)
Table 15. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Trends
Table 16. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers
Table 17. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
Table 18. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
Table 19. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Players (2020-2025)
Table 21. Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2024)
Table 22. Ranking of Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Headquarters and Area Served
Table 25. Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Product and Application
Table 26. Global Key Players of Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2020-2025)
Table 30. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2026-2031)
Table 32. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2020-2025)
Table 34. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2026-2031)
Table 36. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 51. 1ST Biotherapeutics Company Details
Table 52. 1ST Biotherapeutics Business Overview
Table 53. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 54. 1ST Biotherapeutics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 55. 1ST Biotherapeutics Recent Development
Table 56. 3B Pharmaceuticals Company Details
Table 57. 3B Pharmaceuticals Business Overview
Table 58. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 59. 3B Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 60. 3B Pharmaceuticals Recent Development
Table 61. 3D-Micromac Company Details
Table 62. 3D-Micromac Business Overview
Table 63. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 64. 3D-Micromac Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 65. 3D-Micromac Recent Development
Table 66. 3DMed Company Details
Table 67. 3DMed Business Overview
Table 68. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 69. 3DMed Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 70. 3DMed Recent Development
Table 71. 3D Systems Company Details
Table 72. 3D Systems Business Overview
Table 73. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 74. 3D Systems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 75. 3D Systems Recent Development
Table 76. 10X Genomics Company Details
Table 77. 10X Genomics Business Overview
Table 78. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 79. 10X Genomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 80. 10X Genomics Recent Development
Table 81. A*STAR Agency for Science Company Details
Table 82. A*STAR Agency for Science Business Overview
Table 83. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 84. A*STAR Agency for Science Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 85. A*STAR Agency for Science Recent Development
Table 86. Technology and Research Company Details
Table 87. Technology and Research Business Overview
Table 88. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 89. Technology and Research Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Technology and Research Recent Development
Table 91. A*STAR Institute of Microelectronics (IME) Company Details
Table 92. A*STAR Institute of Microelectronics (IME) Business Overview
Table 93. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 94. A*STAR Institute of Microelectronics (IME) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 95. A*STAR Institute of Microelectronics (IME) Recent Development
Table 96. A2A Pharmaceuticals Company Details
Table 97. A2A Pharmaceuticals Business Overview
Table 98. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 99. A2A Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 100. A2A Pharmaceuticals Recent Development
Table 101. Abbvie Company Details
Table 102. Abbvie Business Overview
Table 103. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 104. Abbvie Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 105. Abbvie Recent Development
Table 106. AbCellera Company Details
Table 107. AbCellera Business Overview
Table 108. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 109. AbCellera Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 110. AbCellera Recent Development
Table 111. ABL Bio Company Details
Table 112. ABL Bio Business Overview
Table 113. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 114. ABL Bio Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 115. ABL Bio Recent Development
Table 116. Abpro Company Details
Table 117. Abpro Business Overview
Table 118. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 119. Abpro Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 120. Abpro Recent Development
Table 121. Academy of Military Medical Sciences (China) Company Details
Table 122. Academy of Military Medical Sciences (China) Business Overview
Table 123. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 124. Academy of Military Medical Sciences (China) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 125. Academy of Military Medical Sciences (China) Recent Development
Table 126. Accellix Company Details
Table 127. Accellix Business Overview
Table 128. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 129. Accellix Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 130. Accellix Recent Development
Table 131. Accord Healthcare Company Details
Table 132. Accord Healthcare Business Overview
Table 133. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 134. Accord Healthcare Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 135. Accord Healthcare Recent Development
Table 136. AccuGenomics Company Details
Table 137. AccuGenomics Business Overview
Table 138. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 139. AccuGenomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 140. AccuGenomics Recent Development
Table 141. ACEA Biosciences Company Details
Table 142. ACEA Biosciences Business Overview
Table 143. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 144. ACEA Biosciences Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 145. ACEA Biosciences Recent Development
Table 146. AC Immune Company Details
Table 147. AC Immune Business Overview
Table 148. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 149. AC Immune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 150. AC Immune Recent Development
Table 151. Acoustic MedSystems Company Details
Table 152. Acoustic MedSystems Business Overview
Table 153. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 154. Acoustic MedSystems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 155. Acoustic MedSystems Recent Development
Table 156. Adaptimmune Company Details
Table 157. Adaptimmune Business Overview
Table 158. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 159. Adaptimmune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 160. Adaptimmune Recent Development
Table 161. Aduro BioTech Company Details
Table 162. Aduro BioTech Business Overview
Table 163. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 164. Aduro BioTech Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 165. Aduro BioTech Recent Development
Table 166. Advaxis Company Details
Table 167. Advaxis Business Overview
Table 168. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 169. Advaxis Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 170. Advaxis Recent Development
Table 171. Adventus Ventures Company Details
Table 172. Adventus Ventures Business Overview
Table 173. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 174. Adventus Ventures Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 175. Adventus Ventures Recent Development
Table 176. Aerolase Company Details
Table 177. Aerolase Business Overview
Table 178. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 179. Aerolase Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025) & (US$ Million)
Table 180. Aerolase Recent Development
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
Table 184. Authors List of This Report
List of Figures
Figure 1. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Picture
Figure 2. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Asset purchase Features
Figure 5. Assignment Features
Figure 6. Co-development Features
Figure 7. Co-market Features
Figure 8. Co-promotion Features
Figure 9. Collaborative R&D Features
Figure 10. Contract service Features
Figure 11. CRADA Features
Figure 12. Cross-licensing Features
Figure 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application: 2024 VS 2031
Figure 15. Industry sector Case Studies
Figure 16. Therapy areas Case Studies
Figure 17. Technology type Case Studies
Figure 18. Deal components Case Studies
Figure 19. Financial terms Case Studies
Figure 20. Stage of development Case Studies
Figure 21. Others Case Studies
Figure 22. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report Years Considered
Figure 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region: 2024 VS 2031
Figure 26. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Players in 2024
Figure 27. Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2024)
Figure 28. The Top 10 and 5 Players Market Share by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue in 2024
Figure 29. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2020-2031)
Figure 31. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2020-2031)
Figure 35. Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Nordic Countries Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2020-2031)
Figure 43. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2020-2031)
Figure 51. Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2020-2031)
Figure 55. Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. 1ST Biotherapeutics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 59. 3B Pharmaceuticals Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 60. 3D-Micromac Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 61. 3DMed Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 62. 3D Systems Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 63. 10X Genomics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 64. A*STAR Agency for Science Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 65. Technology and Research Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 66. A*STAR Institute of Microelectronics (IME) Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 67. A2A Pharmaceuticals Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 68. Abbvie Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 69. AbCellera Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 70. ABL Bio Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 71. Abpro Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 72. Academy of Military Medical Sciences (China) Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 73. Accellix Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 74. Accord Healthcare Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 75. AccuGenomics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 76. ACEA Biosciences Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 77. AC Immune Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 78. Acoustic MedSystems Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 79. Adaptimmune Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 80. Aduro BioTech Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 81. Advaxis Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 82. Adventus Ventures Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 83. Aerolase Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2020-2025)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
